nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinnarizine—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.647	0.691	CbGbCtD
Cinnarizine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.289	0.309	CbGbCtD
Cinnarizine—Naftifine—SIGMAR1—amyotrophic lateral sclerosis	0.0057	1	CrCbGaD
Cinnarizine—CACNA1I—cerebellum—amyotrophic lateral sclerosis	0.00142	0.068	CbGeAlD
Cinnarizine—DRD2—nerve—amyotrophic lateral sclerosis	0.00139	0.0663	CbGeAlD
Cinnarizine—CACNA1I—brain—amyotrophic lateral sclerosis	0.00115	0.0552	CbGeAlD
Cinnarizine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00104	0.0497	CbGeAlD
Cinnarizine—CACNA1G—nervous system—amyotrophic lateral sclerosis	0.00103	0.0495	CbGeAlD
Cinnarizine—CACNA1G—central nervous system—amyotrophic lateral sclerosis	0.000996	0.0477	CbGeAlD
Cinnarizine—CACNA1G—cerebellum—amyotrophic lateral sclerosis	0.000974	0.0466	CbGeAlD
Cinnarizine—CACNA1G—brain—amyotrophic lateral sclerosis	0.000791	0.0378	CbGeAlD
Cinnarizine—CACNA1H—nervous system—amyotrophic lateral sclerosis	0.000677	0.0324	CbGeAlD
Cinnarizine—CACNA1H—cerebellum—amyotrophic lateral sclerosis	0.000637	0.0305	CbGeAlD
Cinnarizine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000624	0.0299	CbGeAlD
Cinnarizine—DRD2—brainstem—amyotrophic lateral sclerosis	0.000595	0.0285	CbGeAlD
Cinnarizine—CACNA1D—nervous system—amyotrophic lateral sclerosis	0.000559	0.0267	CbGeAlD
Cinnarizine—CACNA1D—central nervous system—amyotrophic lateral sclerosis	0.000538	0.0257	CbGeAlD
Cinnarizine—CACNA1D—cerebellum—amyotrophic lateral sclerosis	0.000526	0.0252	CbGeAlD
Cinnarizine—CACNA1H—brain—amyotrophic lateral sclerosis	0.000517	0.0248	CbGeAlD
Cinnarizine—CACNA1C—nervous system—amyotrophic lateral sclerosis	0.000516	0.0247	CbGeAlD
Cinnarizine—CACNA1C—central nervous system—amyotrophic lateral sclerosis	0.000497	0.0238	CbGeAlD
Cinnarizine—CACNA1C—cerebellum—amyotrophic lateral sclerosis	0.000485	0.0232	CbGeAlD
Cinnarizine—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000471	0.0226	CbGeAlD
Cinnarizine—CACNA1D—brain—amyotrophic lateral sclerosis	0.000427	0.0204	CbGeAlD
Cinnarizine—CACNA1C—brain—amyotrophic lateral sclerosis	0.000394	0.0189	CbGeAlD
Cinnarizine—CYP2A6—brain—amyotrophic lateral sclerosis	0.000383	0.0183	CbGeAlD
Cinnarizine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000358	0.0171	CbGeAlD
Cinnarizine—DRD2—nervous system—amyotrophic lateral sclerosis	0.000312	0.0149	CbGeAlD
Cinnarizine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.0003	0.0144	CbGeAlD
Cinnarizine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000293	0.014	CbGeAlD
Cinnarizine—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.00026	0.0124	CbGeAlD
Cinnarizine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000252	0.0121	CbGeAlD
Cinnarizine—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.00025	0.012	CbGeAlD
Cinnarizine—HRH1—nervous system—amyotrophic lateral sclerosis	0.000246	0.0118	CbGeAlD
Cinnarizine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000243	0.0116	CbGeAlD
Cinnarizine—DRD2—brain—amyotrophic lateral sclerosis	0.000238	0.0114	CbGeAlD
Cinnarizine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000237	0.0113	CbGeAlD
Cinnarizine—CYP1A1—brain—amyotrophic lateral sclerosis	0.000198	0.00949	CbGeAlD
Cinnarizine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000193	0.00922	CbGeAlD
Cinnarizine—HRH1—brain—amyotrophic lateral sclerosis	0.000188	0.00901	CbGeAlD
Cinnarizine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000187	0.00897	CbGeAlD
Cinnarizine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00018	0.00863	CbGeAlD
Cinnarizine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000176	0.00844	CbGeAlD
Cinnarizine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000143	0.00685	CbGeAlD
Cinnarizine—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.36e-05	0.00248	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	9.35e-05	0.00248	CbGpPWpGaD
Cinnarizine—CACNA1D—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	9.29e-05	0.00246	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.26e-05	0.00245	CbGpPWpGaD
Cinnarizine—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	9.21e-05	0.00244	CbGpPWpGaD
Cinnarizine—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	9.09e-05	0.00241	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—MMP9—amyotrophic lateral sclerosis	9e-05	0.00239	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—DAO—amyotrophic lateral sclerosis	8.96e-05	0.00237	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	8.94e-05	0.00237	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	8.84e-05	0.00234	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	8.84e-05	0.00234	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—FIG4—amyotrophic lateral sclerosis	8.71e-05	0.00231	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.7e-05	0.0023	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	8.68e-05	0.0023	CbGpPWpGaD
Cinnarizine—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.47e-05	0.00224	CbGpPWpGaD
Cinnarizine—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	8.27e-05	0.00219	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	8.18e-05	0.00217	CbGpPWpGaD
Cinnarizine—CACNA1C—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	8.17e-05	0.00216	CbGpPWpGaD
Cinnarizine—CACNA1I—Axon guidance—VEGFA—amyotrophic lateral sclerosis	8.09e-05	0.00214	CbGpPWpGaD
Cinnarizine—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.98e-05	0.00211	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—DAO—amyotrophic lateral sclerosis	7.87e-05	0.00209	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	7.63e-05	0.00202	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—C3—amyotrophic lateral sclerosis	7.6e-05	0.00201	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	6.98e-05	0.00185	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	6.97e-05	0.00185	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	6.97e-05	0.00185	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—PLB1—amyotrophic lateral sclerosis	6.79e-05	0.0018	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	6.73e-05	0.00178	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—MMP9—amyotrophic lateral sclerosis	6.64e-05	0.00176	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	6.61e-05	0.00175	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	6.55e-05	0.00174	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.52e-05	0.00173	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.49e-05	0.00172	CbGpPWpGaD
Cinnarizine—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	6.48e-05	0.00172	CbGpPWpGaD
Cinnarizine—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.44e-05	0.00171	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—MMP9—amyotrophic lateral sclerosis	6.43e-05	0.0017	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—MMP9—amyotrophic lateral sclerosis	6.43e-05	0.0017	CbGpPWpGaD
Cinnarizine—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.35e-05	0.00168	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—GSR—amyotrophic lateral sclerosis	6.27e-05	0.00166	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—VCP—amyotrophic lateral sclerosis	6.21e-05	0.00165	CbGpPWpGaD
Cinnarizine—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.17e-05	0.00164	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	6.11e-05	0.00162	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	6.11e-05	0.00162	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.1e-05	0.00162	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.01e-05	0.00159	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—PLB1—amyotrophic lateral sclerosis	5.97e-05	0.00158	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.96e-05	0.00158	CbGpPWpGaD
Cinnarizine—CACNA1G—Axon guidance—VEGFA—amyotrophic lateral sclerosis	5.96e-05	0.00158	CbGpPWpGaD
Cinnarizine—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.94e-05	0.00157	CbGpPWpGaD
Cinnarizine—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.86e-05	0.00155	CbGpPWpGaD
Cinnarizine—CACNA1H—Axon guidance—VEGFA—amyotrophic lateral sclerosis	5.77e-05	0.00153	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	5.77e-05	0.00153	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	5.64e-05	0.00149	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.6e-05	0.00148	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	5.59e-05	0.00148	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.54e-05	0.00147	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—GSR—amyotrophic lateral sclerosis	5.51e-05	0.00146	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—MMP9—amyotrophic lateral sclerosis	5.46e-05	0.00145	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.34e-05	0.00141	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.28e-05	0.0014	CbGpPWpGaD
Cinnarizine—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.27e-05	0.0014	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.21e-05	0.00138	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.2e-05	0.00138	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—CHAT—amyotrophic lateral sclerosis	5.15e-05	0.00136	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	4.93e-05	0.00131	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	4.93e-05	0.00131	CbGpPWpGaD
Cinnarizine—CACNA1S—Axon guidance—VEGFA—amyotrophic lateral sclerosis	4.9e-05	0.0013	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.89e-05	0.00129	CbGpPWpGaD
Cinnarizine—DRD2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	4.85e-05	0.00129	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.74e-05	0.00126	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—MMP9—amyotrophic lateral sclerosis	4.59e-05	0.00122	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.55e-05	0.00121	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.55e-05	0.00121	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—CHAT—amyotrophic lateral sclerosis	4.52e-05	0.0012	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	4.51e-05	0.0012	CbGpPWpGaD
Cinnarizine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.47e-05	0.00119	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.44e-05	0.00118	CbGpPWpGaD
Cinnarizine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.43e-05	0.00118	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—MMP9—amyotrophic lateral sclerosis	4.43e-05	0.00117	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	4.42e-05	0.00117	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.41e-05	0.00117	CbGpPWpGaD
Cinnarizine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.41e-05	0.00117	CbGpPWpGaD
Cinnarizine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.37e-05	0.00116	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.3e-05	0.00114	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.25e-05	0.00113	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.25e-05	0.00113	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.19e-05	0.00111	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.18e-05	0.00111	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.17e-05	0.0011	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.12e-05	0.00109	CbGpPWpGaD
Cinnarizine—CACNA1D—Axon guidance—VEGFA—amyotrophic lateral sclerosis	3.98e-05	0.00105	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	3.94e-05	0.00104	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.9e-05	0.00103	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.89e-05	0.00103	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—MMP9—amyotrophic lateral sclerosis	3.89e-05	0.00103	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.87e-05	0.00103	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.86e-05	0.00102	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.8e-05	0.00101	CbGpPWpGaD
Cinnarizine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.79e-05	0.001	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	3.79e-05	0.001	CbGpPWpGaD
Cinnarizine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.74e-05	0.00099	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	3.73e-05	0.00099	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.64e-05	0.000965	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.63e-05	0.000961	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.57e-05	0.000947	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	3.57e-05	0.000945	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	3.5e-05	0.000926	CbGpPWpGaD
Cinnarizine—CACNA1C—Axon guidance—VEGFA—amyotrophic lateral sclerosis	3.49e-05	0.000926	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.45e-05	0.000915	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.43e-05	0.000908	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.43e-05	0.000908	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.4e-05	0.000901	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	3.4e-05	0.0009	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	3.4e-05	0.0009	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.39e-05	0.000899	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.35e-05	0.000887	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	3.29e-05	0.000872	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.24e-05	0.000858	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.17e-05	0.00084	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.16e-05	0.000837	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.14e-05	0.000831	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	3.11e-05	0.000824	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	3.09e-05	0.000819	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.94e-05	0.000778	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.91e-05	0.000772	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.9e-05	0.000769	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.9e-05	0.000769	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.89e-05	0.000766	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	2.88e-05	0.000764	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.84e-05	0.000752	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.78e-05	0.000736	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.77e-05	0.000735	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.77e-05	0.000733	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.74e-05	0.000726	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.72e-05	0.00072	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.71e-05	0.000717	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.7e-05	0.000716	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.69e-05	0.000713	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.66e-05	0.000704	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.64e-05	0.0007	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.61e-05	0.000691	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.54e-05	0.000674	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.54e-05	0.000673	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.53e-05	0.000671	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.5e-05	0.000661	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	2.49e-05	0.000661	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.49e-05	0.000661	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.49e-05	0.000659	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	2.48e-05	0.000657	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.47e-05	0.000654	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.46e-05	0.000651	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.43e-05	0.000644	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.4e-05	0.000636	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.36e-05	0.000624	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.32e-05	0.000616	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.32e-05	0.000615	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.3e-05	0.000611	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.3e-05	0.00061	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.28e-05	0.000605	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.23e-05	0.000592	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.15e-05	0.000568	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.1e-05	0.000556	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.1e-05	0.000556	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—APOE—amyotrophic lateral sclerosis	2.09e-05	0.000554	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	2.09e-05	0.000553	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.06e-05	0.000547	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.05e-05	0.000543	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.04e-05	0.000541	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.03e-05	0.000537	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2e-05	0.000531	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.89e-05	0.000501	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.88e-05	0.000498	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.86e-05	0.000493	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—APOE—amyotrophic lateral sclerosis	1.84e-05	0.000487	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.77e-05	0.00047	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.73e-05	0.000459	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.73e-05	0.000457	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.72e-05	0.000455	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.71e-05	0.000452	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.67e-05	0.000444	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.66e-05	0.00044	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	1.63e-05	0.000432	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.59e-05	0.000422	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.000415	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.51e-05	0.000399	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.48e-05	0.000392	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.47e-05	0.000389	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.43e-05	0.00038	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.42e-05	0.000377	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.41e-05	0.000374	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.4e-05	0.000371	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.38e-05	0.000365	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.36e-05	0.000362	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.36e-05	0.000361	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.34e-05	0.000354	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.31e-05	0.000348	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.29e-05	0.000342	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.29e-05	0.000342	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.29e-05	0.000341	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.26e-05	0.000334	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.25e-05	0.000332	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.25e-05	0.000332	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.23e-05	0.000326	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.21e-05	0.00032	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.18e-05	0.000313	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.16e-05	0.000307	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.1e-05	0.000292	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.1e-05	0.000292	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.07e-05	0.000284	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.05e-05	0.000279	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	1.03e-05	0.000273	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.02e-05	0.000269	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000268	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000267	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.89e-06	0.000262	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.34e-06	0.000247	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.91e-06	0.000236	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.82e-06	0.000234	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.75e-06	0.000232	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.74e-06	0.000232	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	8.32e-06	0.000221	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.29e-06	0.00022	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.14e-06	0.000216	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	7.68e-06	0.000204	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.65e-06	0.000203	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.58e-06	0.000201	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.54e-06	0.0002	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.07e-06	0.000187	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.03e-06	0.000186	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.97e-06	0.000185	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.85e-06	0.000182	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.73e-06	0.000178	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.48e-06	0.000172	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.96e-06	0.000158	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	5.78e-06	0.000153	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	5.73e-06	0.000152	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.7e-06	0.000151	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.27e-06	0.00014	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.27e-06	0.00014	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.18e-06	0.000137	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.98e-06	0.000132	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.9e-06	0.00013	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.89e-06	0.00013	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.48e-06	0.000119	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.39e-06	0.000116	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.96e-06	0.000105	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.93e-06	0.000104	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.38e-06	8.96e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.36e-06	8.9e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.32e-06	8.8e-05	CbGpPWpGaD
